Most tests used in clinical medicine give a numerical result on a continuous measurement scale. Pathologists or clinicians attempt to interpret the result by comparing it with a "reference range" previously calculated from a study of people who do not have the disease in question. By current convention, the reference range includes all but the top and bottom 2 5% of the results expected from a population of healthy people, so that 5% of the "normal" healthy population will have test values falling outside the reference range. Consequently, the fact that the test result for an individual subject is outside the reference range does not necessarily imply that the individual is abnormal-this is one reason why the older term "normal range" is becoming obsolete.
Reference ranges
Most tests used in clinical medicine give a numerical result on a continuous measurement scale. Pathologists or clinicians attempt to interpret the result by comparing it with a "reference range" previously calculated from a study of people who do not have the disease in question. By current convention, the reference range includes all but the top and bottom 2 5% of the results expected from a population of healthy people, so that 5% of the "normal" healthy population will have test values falling outside the reference range. Consequently, the fact that the test result for an individual subject is outside the reference range does not necessarily imply that the individual is abnormal-this is one reason why the older term "normal range" is becoming obsolete.
A reference range may be determined from test values obtained from a sample of healthy subjects provided: (i) the subjects constitute a random sample from the healthy portion ofthe population; and (ii) the sample size is sufficiently large for it to be representative of the population and for the sample mean and standard deviation to be precise estimates of the population mean and standard deviation.
If the population distribution of the test results is normal, then 95% of all values will lie within the range population mean ± 1 96 (population standard deviation) (Article 2). The sample mean and standard deviation are estimates of the unknown population mean and standard deviation and by convention the reference range is taken to be: sample mean ± 1-96 (sample standard deviation)
Accepted for publication 12 December 1988 The sample mean and standard deviation, however, are subject to sampling variation-that is, each random sample gives rise to different sample statisticsand so the limits of the reference range will be imprecise. Confidence intervals can be calculated for the upper and lower reference limits to indicate the imprecision of the reference range. If the sample size is large a 95% confidence interval for each end of the reference range is: reference limit ± 1-96 1/3 (SE mean).
The method for calculation can be illustrated by data . Thus the reference range based on percentiles and allowing for uncertainty in the percentiles is 19 to 1995, which is not very different from that found by using the previous method based on the assumption of normality of log RAST count.
There are several sources of variation which are likely to affect the test value produced by any well monitored and accurately calibrated analytical technique for a given subject: for example, (a) inherent random error in the analysis of the sample, usually monitored by quality control methods; (b) timerelated variation; (c) variation associated with physiological changes; (d) variation associated with external factors such as diet, tobacco, or alcohol consumption, exercise, posture and so on before taking the test specimen. Such factors will tend to increase the variability of results and, in the absence of information about the magnitude of their effects on variability, it may be difficult to interpret a result which lies "just outside" the reference range; thus a healthy subject who has a "true" value close to the upper reference limit may give a test result above the limit. Similarly, a diseased subject who has a "true" value above the upper reference limit could be within the reference range when tested.
Assessment of diagnostic tests
In view of the uncertainties inherent in comparing a test result with a reference range it is worth while examining the criteria that should be used in assessing and choosing diagnostic tests.34 To assess a particular diagnostic method results must first be obtained from a group of persons who have the fully developed disease and a group in which the disease is absent. In practice, diagnostic tests are often used to assess patients who are in the early stages of disease; this raises the question of whether comparison of the above groups addresses the correct question. The criteria for determining the presence and absence of the disease in these two groups must be carefully stated and should be in accord with standard well understood If the initial studies on a proposed new diagnostic method were based on 350 healthy subjects and 350 patients with pulmonary tuberculosis who had been diagnosed as having the disease on the basis of some independent, well defined, and accepted criterion (in this case chest x-ray pictures), the test results might be as shown in fig 1. The investigator might perform a Mann-Whitney U test (Article 3) as the test results are not normally distributed, the resulting p value being less than 0-0001.
The investigator would be wrong to conclude from this that the assay has high diagnostic value because the Mann-Whitney U test is designed to answer the question: "do the data provide evidence of a difference in the medians of the population distributions for healthy and diseased individuals?" This is largely irrelevant for judging the clinical value of a diagnostic test, where the critical decision must involve a notion of a cut off point to assist in decision taking. In practice, values above a certain critical limit will be regarded as indicating that the patient has the disease, and lower values that it is unlikely that the patient has the disease. The pertinent question must concern not merely the separation between the medians (or means) of the corresponding population distributions for the healthy and diseased groups but separation of the distributions as a whole. It is relatively common for the distributions to overlap, and this raises the possibility that a healthy subject will be classified as diseased or that a diseased subject may be classified as healthy.
Assessment of a diagnostic test must concentrate on such issues and look at the risks of misclassification.
As the initial assessment of the value of the proposed new test depends on its application to a group of patients with clearly established disease and to people who are definitely healthy the results for any selected cut off point can be summarised in a 2 x 2 table (fig 2) . The sensitivity of a test is defined as the proportion of the patients who have the disease in whom the test result is positive (a/(a + c) ), and this is a measure of the probability that a person who has the disease will give a positive test result. The specificity of a test is defined as the proportion ofhealthy subjects in whom the test result is negative (d/b + d) ), and this measures the probability that a healthy person will give a negative test result. Thefalse positive rate is the proportion of the healthy subjects who give a positive test result (b/b + d) ), and thefalse negative rate is the proportion of those subjects who have the disease but who give a negative test result (c/(a + c) ). When selecting a test it is necessary to compare the sensitivity and specificity of the available tests. As a general rule the test with the highest sensitivity should be selected for clinical diagnosis unless its specificity is unacceptably low. When a test is to be applied for screening purposes it can be argued that it is important that as large a proportion as possible ofthose who give a positive test result do, in fact, have the disease the screening program is meant to detect, and so the sensitivity should be high. A test used to confirm a diagnosis should have a high specificity-that is, it should produce a negative result in a high proportion of those who do not have the disease.
The sensitivity and specificity of a test can be changed by altering the criterion for positivity. When the test gives numerical values on a continuous scale a cut off point is used to define the boundary between positive and negative results. For example, in fig 1 a cut off point at 500 (log 500 = 1-699) results in a sensitivity of 66% and a specificity of 77%. By moving the cut offpoint down the scale a greater proportion of diseased subjects will give a positive tests result so the sensitivity increases, but this occurs at the cost offewer subjects without the disease giving a negative resultthat is, decreasing specificity. The receiver-operator characteristic (ROC) curve of a test is a graph which is constructed by plotting for a series of cut off points, the sensitivity (true positive rate) against the false positive rate (100-specificity). This curve is shown in fig 4 for the data displayed in fig 1, and it is apparent that the test can not provide a very high true positive rate coupled with a low false positive rate. The ROC may be used to determine the optimal cut off point for the test according to the costs and benefits (in the widest sense) resulting from correct and incorrect diagnoses. Competing tests may be assessed by comparing their ROC curves.
The probability that a patient with a positive test result has the disease depends not only on the sensitivity and specificity of the test but also on the pretest or prior estimate of the probability that a patient presenting with a particular combination of signs and symptoms has the disease. Note that an investigation designed to assess a test and determine its ROC curve does not provide this information as the assessment will be based on roughly equal numbers ofhealthy and diseased persons. 0-959 0-220 probability must be based on past experience of the prevalence of the disease among patients with the specified signs and symptoms. Ifthe prior estimate was, for example, 50%-that is, in 2000 patients presenting one would expect 1000 to have the disease-then the data from the test evaluation may be combined with this information to give the results shown in fig 5. Of the 1000 patients with the disease, 714 will give a positive test result, and 274 of the 1000 patients who do not have the disease will also be positive. Consequently one should expect 988 positive test results and the proportion of diseased patients among these to be 714/988 or 72-3. Thus a positive test result converts a 50% chance that the patient has the disease into a 72% chance.
The positive predictive value (PPV) of a positive test result is the probability that a patient who gives a positive test has the disease and thepredictive value ofa negative result (PVN) is the corresponding probability that a patient with a negative result does not have the disease. The table shows the positive and negative predictive value for prior estimates ranging from 10% to 90% when the sensitivity and specificity of the test are 71 4% and 72-6%. In this case the results are not particularly impressive, which is a reflection of the fact that the RAST count is not a good diagnostic indicator in this particular situation.
It must be borne in mind that the results of an assessment of a diagnostic test which compares those without the disease and those with fully developed disease are likely to overstate the predictive value of a positive or a negative result when the test is applied to patients who do not have the fully developed disease as the distribution of test results in such patients is likely to be closer to that of the disease-free group than the distribution of test results from patients with fully developed disease.
Discrimninant analysis
There are many clinical situations in which a single diagnostic test may not be sufficiently specific or sensitive to diagnose a disease and it is usual to perform two or more different tests and base the diagnosis on the combined results. The assessment of such situations leads naturally to investigation of the Brown, Swanson Beck emphasise the importance of using statistical analysis to answer the right questions. It will be apparent from the discussion of the misuse of correlation and regression in comparison of laboratory methods and in the discussion on the evaluation of diagnostic tests in this article that it is sometimes easy to lose sight of the questions central to the scientist's investigations in the search for a convenient statistical technique. The investigator should always remember that it is stupid to use the wrong technique to answer an irrelevant question. This situation can be avoided by asking a number of questions at the beginning of the investigation: (a) what is the precise aim of the investigation? (b) if a very large amount of a particular type of data was available, would it provide the answer to the questions being asked? (c) is the investigation concerned with differences or similarities between groups? (d) is the investigation large enough to detect clinically important differences?
Finally, one should attempt to clear one's mind of the idea that all that is important is the calculation of some result (any result) which has a p value small enough to allow the result to be declared "significant". Many statistical text books with a heavy emphasis on significance testing do not help in this respect. At the risk of boring the reader we will reiterate our view that significance should always be related to clinical or biological significance, and a full measure of common sense (with clinical or scientific insight) should be exercised in planning an investigation and interpreting its results.
